Industry Symposia
Loading view.
Industry Symposium
c-Met Dysregulation: Targeted Agents and Their Emerging Role in Advanced NSCLC
Hall C7
Sponsored by Abbvie Global
Industry Symposium
Future Directions in NSCLC: Tailoring Treatment Options
Hall C2
Sponsored by Mirati Therapeutics
Industry Symposium
Novel Anti–PD-(L)1/Anti-TIGIT Combinations: Are These Breaking New Ground in NSCLC?
Hall C1
Sponsored by Novartis
Industry Symposium
Decisive Moments in the Treatment of MET exon 14 Skipping NSCLC
Hall C7
Sponsored by Merck KGaA Darmstadt
Industry Symposium
Precision Medicine in Lung Cancer: Learnings from Established and Emerging Targets
Hall C8
Sponsored by Takeda
Industry Symposium
Is it Time to Raise the Bar for ALK+ NSCLC Patients?
Hall C2
Sponsored by Pfizer
Industry Symposium
Disrupting the Treatment Paradigm in SCLC: Current and Future Perspectives
Hall C7
Sponsored by AstraZeneca
Industry Symposium
A New Frontier: Emerging Biomarkers and Antibody-Drug Conjugates in Advanced NSCLC
Hall C8
Sponsored by Sanofi
Industry Symposium
Driving Advancements in the Treatment of Lung Cancer
Hall C8
Sponsored by Amgen Inc.
Industry Symposium
Expanding Horizons in Metastatic NSCLC: Unmet Need and Future Directions
Hall C7
Sponsored by AstraZeneca
Industry Symposium
Expanding Horizons for the Targeted Management of EGFR-Mutant NSCLC
Strauss 3
Sponsored by Janssen Pharmaceuticals
Industry Symposium
Harnessing the Full Potential of Immunotherapy in Frontline Treatment of Locally Advanced or Metastatic NSCLC
Hall C7
Sponsored by RMEI Medical Education, LLC, and supported by Regeneron and Sanofi
Industry Symposium
Current and Future Management of Patients with Advanced EGFRm NSCLC Progressing on Third-Generation EGFR-TKIs
Hall C7
Sponsored by AstraZeneca
Industry Symposium
The Expanding Toolbox: Key Updates for ADCs in Lung Cancer
Strauss 3
Sponsored by Daiichi Sankyo, Inc.
Industry Symposium
Breaking Barriers with Immunotherapy in Squamous Cell Carcinoma of the Lung: Challenges and Opportunities in Management
Hall C8
Sponsored by Sanofi Regeneron
Industry Symposium
New Frontiers in the Management of NSCLC
Hall C7
Sponsored by MSD